Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

146.39 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income
Via The Motley Fool
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025
Via The Motley Fool
Topics Stocks
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase
From Zoetis Inc.
Via Business Wire
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,400 Today
 
Via Benzinga
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Zoetis Inc.
Via Business Wire
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback
Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip. 
Via The Motley Fool
Topics Stocks
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role
From Zoetis Inc.
Via Business Wire
Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today
 
Via Benzinga
In-Depth Examination Of 7 Analyst Recommendations For Zoetis
 
Via Benzinga
$1000 Invested In Zoetis 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Zoetis to Participate in Jefferies London Healthcare Conference
From Zoetis Inc.
Via Business Wire
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Wall Street rallied on Tuesday as improved investor sentiment aligned with millions of Americans casting their votes for the 47th president. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Where Zoetis Stands With Analysts
 
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
 
Via Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst
Zoetis Inc's Q3 2024 results show a 16% EPS increase and an 11% revenue boost. The company raises its 2024 guidance, highlighting strong global growth in key segments. 
Via Benzinga
Topics Earnings
Zoetis (ZTS) Q3 2024 Earnings Call Transcript
ZTS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips
Zoetis stock inched higher Monday after the animal health company beat third-quarter expectations and raised its outlook. 
Via Investor's Business Daily
Zoetis Announces Third Quarter 2024 Results
From Zoetis Inc.
Via Business Wire
'Venture Investing Is Random,' Says Kevin O'Leary. The Craziest Bets, Like Cat DNA Tests, Often Cover All The Losses
 
Via Benzinga
Zoetis Declares Fourth Quarter 2024 Dividend
From Zoetis Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Zoetis and Danone Announce Strategic Partnership to Pioneer Sustainable Innovation in Dairy Farming Using the Power of Genetics
From Zoetis Inc.
Via Business Wire
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to... 
Via Benzinga
Zoetis to Host Webcast and Conference Call on Third Quarter 2024 Financial Results
From Zoetis Inc.
Via Business Wire
Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.